{"title": "Health System | Page 25", "author": null, "url": "https://www.ajmc.com/stakeholders/health-system", "hostname": "ajmc.com", "description": "The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.", "sitename": "AJMC", "date": "2020-04-14", "cleaned_text": "September 8th 2023 New research suggests conventional fractionated and hypofractionated proton postmastectomy radiotherapy (PMRT) yield similar tolerability for patients following mastectomy. [What We're Reading: J&J Blood Clot Concerns; Abortion Pill Access; Pandemic Health Spending](/view/what-we-re-reading-j-j-blood-clot-concerns-abortion-pill-access-pandemic-health-spending) The CDC is recommending that people at risk of developing blood clots receive the Moderna or Pfizer/BioNTech vaccines instead of Johnson & Johnson (J&J); the FDA lifts restrictions on mail order access to abortion pills; US health care spending more than doubled during the first year of the pandemic. Read More [What We're Reading: Moderna Vaccine Efficacy Reduced; Vaccine Mandate Revived; New Combo Against Breast Cancer](/view/what-we-re-reading-moderna-vaccine-efficacy-reduced-vaccine-mandate-revived-new-combo-against-breast-cancer) Two doses of the Moderna COVID-19 vaccine have reduced efficacy against the Omicron variant; a federal appeals court reinstates the Biden administration's health care worker vaccine mandate in 26 states; a new combination therapy may reduce breast cancer progression. Read More [Comorbid Psoriasis, NAFLD Linked With Significantly Impaired Kidney Function](/view/comorbid-psoriasis-nafld-linked-with-significantly-impaired-kidney-function) Patients with comorbid nonalcoholic fatty liver disease (NAFLD) and chronic plaque psoriasis were shown to have significantly lower estimated glomerular filtration rate levels and greater prevalence of more advanced chronic kidney disease. Read More [POLARIX: Upgrading R-CHOP With Polatuzumab Vedotin for Vincristine Improves Progression-Free Survival ](/view/polarix-upgrading-r-chop-with-polatuzumab-vedotin-for-vincristine-improves-progression-free-survival) Results presented at the 63rd Annual American Society of Hematology Meeting showed that using polatuzumab vedotin instead of vincristine in R-CHOP improved progression-free survival in patients with newly diagnosed diffuse large B-cell lymphoma. Read More [Dr Frederick Locke on Real-World Implications of ZUMA-7 Findings in Relapsed/Refractory LBCL](/view/dr-frederick-locke-on-real-world-implications-of-zuma-7-findings-in-relapsed-refractory-lbcl) Frederick Locke, MD, vice chair, Department of Blood and Marrow Transplant and Cellular Immunotherapy Program, co-leader, Immuno-Oncology, Moffitt Cancer Center, discusses findings of the phase 3 ZUMA-7 trial presented at ASH 2021 and how use of axicabtagene ciloleucel can be optimally in a real-world [Dr Sattva Neelapu: Axi-Cel Highly Large B-Cell Lymphoma](/view/dr-sattva-neelapu-axi-cel-highly-effective-as-first-line-option-in-high-risk-large-b-cell-lymphoma) Sattva S. Neelapu, MD, professor and deputy department chair in the Department of Lymphoma/Myeloma in the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center, discusses findings of the ZUMA-12 study examining axicabtagene ciloleucel (axi-cel) as a first-line treatment option for with large B-cell lymphoma. Watch [Dr Mark Wildgust at ASH 2021](/view/dr-mark-wildgust-reviews-key-cilta-cel-research-presented-at-ash-2021) Mark Wildgust, PhD, vice president, Global Medical Affairs, Oncology, Janssen, speaks on progression-free survival, complete response, and overall survival benefits observed with ciltacabtagene autoleucel (cilta-cel) in CARTITUDE-1 and other studies presented at the 63rd Annual American Society of Hematology Meeting and Exposition. Watch [Dr Lori Muffly Spotlights Disparities in Clinical Trial Enrollment, Patient Outcomes in Pediatric ALL](/view/dr-lori-muffly-spotlights-disparities-in-clinical-trial-enrollment-patient-outcomes-in-pediatric-all) Lori Muffly, MD, associate professor of medicine, Blood & Marrow Transplantation, Stanford University, discusses findings of her study showing disparities in clinical trial enrollment and patient outcomes for at-risk pediatric minority populations with acute lymphoblastic leukemia (ALL). Watch [Uptake of Artificial Pancreas Systems in Primary Care Could Reduce Care Disparities](/view/uptake-of-artificial-pancreas-systems-in-primary-care-could-reduce-care-disparities) Findings about the willingness of primary care providers to prescribe artificial pancreas systems have positive implications for increasing access to and reducing disparities around this technology by alleviating the need to see a specialist. Read More [Using AI to Detect Early Signs of Parkinson Disease Through Facial Analysis](/view/using-ai-to-detect-early-signs-of-parkinson-disease-through-facial-analysis) Researchers at the University of Rochester are analyzing facial muscle movements through videos taken over webcams or smartphones to train a machine learning algorithm with the hope that it can predict Parkinson disease at an earlier stage. Read More [Dr Andre Goy Previews Key Data on CAR T-Cell Therapy to Be Presented at ASH 2021](/view/dr-andre-goy-previews-key-data-on-car-t-cell-therapy-to-be-presented-at-ash-2021) Andre Goy, MD, MS, chairman and executive director of the John Theurer Cancer Center, provides an overview of the emerging data at ASH 2021 on CAR T-cell therapy as a second- and first-line treatment. Watch [What We're Reading: Pfizer Says Omicron May Require Fourth Dose; CMS Shares ACA Enrollment Figures; City of Hope Makes Acquisition](/view/what-we-re-reading-pfizer-says-omicron-may-require-fourth-dose-cms-share-aca-enrollment-figures-city-of-hope-makes-acquisition) Pfizer predicts that a fourth dose of a COVID-19 vaccine may be needed to quell the Omicron variant; CMS officials share figures on enrollment for health coverage under the Affordable Care Act (ACA); City of Hope announces acquisition of Cancer Treatment Centers of America. Read More [What We're Reading: Immune Response in Mixing Doses; Convalescent Plasma Use Not Effective for COVID-19; Gender Pay Gap Among Doctors](/view/what-we-re-reading-immune-response-in-mixing-doses-convalescent-plasma-use-not-effective-for-covid-19-gender-pay-gap-among-doctors) British study finds higher immune response when mixing Pfizer, AstraZeneca COVID-19 vaccines with Moderna; World Health Organization strongly advises against the use of convalescent plasma to treat COVID-19; disparities in pay by gender among physicians. Read More [Patients With Psoriatic Disease May Have Greater Risk of VTE, PVD ](/view/patients-with-psoriatic-disease-may-have-greater-risk-of-vte-pvd) Patients with psoriasis were found to have a more than 20% increased risk of developing incident venous thromboembolism (VTE) and peripheral vascular disease (PVD), with notable at-risk groups including women and those with concomitant psoriatic arthritis. Read More [What We're Reading: Early Omicron Data; Average Young Adult Overweight; Vaccine Discrimination Risks](/view/what-we-re-reading-early-omicron-data-average-young-adult-overweight-vaccine-discrimination-risks) Early data suggest the Omicron variant may cause less severe cases of COVID-19; a new JAMA study finds the average young adult overweight; spotlighting vaccine discrimination in Africa. Read More [COVID-19 Not Creating Lingering Chronic Cough Impacts, Dr Peter Dicpinigaitis Says](/view/covid-19-not-creating-lingering-chronic-cough-impacts-dr-peter-dicpinigaitis-says) Peter Dicpinigaitis, MD, professor of medicine at the Albert Einstein College of Medicine and director of the Montefiore Cough Center, discusses what he and others have seen during the pandemic in patients with chronic cough who had COVID-19. Watch [Rituximab Infusion Timing, Dosing and COVID-19 Hospitalization Not Linked, Study Says](/view/study-no-relation-detected-between-rituximab-infusion-timing-dosing-and-covid-19-hospitalization-in-ms) A study examining the relation between rituximab infusion and hospitalization as a result of COVID-19 for patients with multiple sclerosis (MS) found that the 2 were not related, contradicting past research. Read More "}